| Physicians
at Regional Orthopaedic Health Care here and in Harrison
are now treating "tennis elbow" with a new
technique recently approved by the federal Food and Drug
Administration (FDA). The new technique is an additional
application of shock wave treatment which is used to
treat chronic heel pain.
The FDA granted approval for use of the HealthTronics
OssaTron® device for performing extracorporeal
shock wave treatment for chronic lateral epicondylitis
or tennis elbow that has failed to respond to conservative
(nonsurgical) treatment. Tennis elbow is considered
chronic if it has continued for six months without
relief from treatments such as strapping, icing, stretching,
strengthening, and anti-inflammatory medication or
injections.
Special training is required to use the OssaTron equipment,
which generates and administers high-energy shock waves
while the patient is under local or regional anesthetic.
Thomas E. Knox is trained to use the OssaTron for the treatment of
tennis elbow.
Argil Wheelock, CEO of HealthTronics, which produces
the OssaTron device, said, "This approval is a
major step forward in our goal to establish the OssaTron
as the most effective choice for the treatment of a
wide variety of chronic orthopaedic conditions."
In tennis elbow, tendons attached to the outside (lateral)
of the elbow are inflamed. The inflammation results
from repetitive activities in which the tendons are
overstressed, such as in sports or activities requiring
constant squeezing or gripping. Pain, which may radiate
to the forearm and hand, occurs with grasping activities.
The condition may be difficult to eradicate because
the tendons are used every time the hand grips or squeezes.
Instead of surgery for tennis elbow, with recovery
ranging up to several months, OssaTron shock wave treatment
(orthotripsy) may result in immediate pain relief,
although it can take up to four weeks for pain relief
to begin. The shock wave treatment increases blood
flow and stimulates healing of the affected elbow.
Orthotripsy was developed in Europe using the same
technology used on kidney stones (lithotripsy).
Prior to FDA approval, a study of 225 patients resulted
in 90 percent of the treated patients receiving a benefit
from orthotripsy and 64 percent having an excellent
or good outcome. The study was multi-center, randomized,
placebo-controlled, and doubled-blinded. The device
is also under study for use on other chronic tendon
injuries.
Regional Orthopaedic Health Care has offices in Mountain
Home at 3 Medical Plaza, phone (870) 424-3400, and
in Harrison at Regions Bank Bldg, Suite 202, phone
1-800-621-3218. Patients do not need a referral to
make an appointment with a physician at Regional Orthopaedic
Health Care.
Regional Orthopaedic Health Care provides bone and
joint disease evaluation, treatment and surgery, arthroscopic
joint surgery, open and endoscopic carpal tunnel release,
sports medicine, laser surgery, hand and shoulder therapy,
in-office nerve conduction studies, evaluation of hand
and wrist injuries, isokinetic exercise equipment,
industrial orthopaedics, physical and occupational
therapy.
|